NO882854D0 - Korreksjon med dobbeltraadet rna av avvikende metabolske spor forbundet med ukontrollerte vekstsykluser for tumorceller og virus. - Google Patents

Korreksjon med dobbeltraadet rna av avvikende metabolske spor forbundet med ukontrollerte vekstsykluser for tumorceller og virus.

Info

Publication number
NO882854D0
NO882854D0 NO882854A NO882854A NO882854D0 NO 882854 D0 NO882854 D0 NO 882854D0 NO 882854 A NO882854 A NO 882854A NO 882854 A NO882854 A NO 882854A NO 882854 D0 NO882854 D0 NO 882854D0
Authority
NO
Norway
Prior art keywords
rna
correction
tumor cell
different metabolic
tracks associated
Prior art date
Application number
NO882854A
Other languages
English (en)
Other versions
NO882854L (no
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of NO882854D0 publication Critical patent/NO882854D0/no
Publication of NO882854L publication Critical patent/NO882854L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO88882854A 1987-07-17 1988-06-28 Korreksjon med dobbeltraadet rna av avvikende metabolske spor forbundet med ukontrollerte vekstsykluser for tumorceller og virus. NO882854L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7464987A 1987-07-17 1987-07-17

Publications (2)

Publication Number Publication Date
NO882854D0 true NO882854D0 (no) 1988-06-28
NO882854L NO882854L (no) 1989-01-18

Family

ID=22120800

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88882854A NO882854L (no) 1987-07-17 1988-06-28 Korreksjon med dobbeltraadet rna av avvikende metabolske spor forbundet med ukontrollerte vekstsykluser for tumorceller og virus.

Country Status (18)

Country Link
EP (2) EP0299745B1 (no)
JP (1) JPH01104015A (no)
KR (1) KR970007903B1 (no)
CN (1) CN1032741A (no)
AT (1) ATE123222T1 (no)
AU (3) AU1820388A (no)
CA (1) CA1331345C (no)
DE (1) DE3853898T2 (no)
DK (1) DK363088A (no)
ES (1) ES2075835T3 (no)
FI (1) FI883351A (no)
GR (1) GR3017271T3 (no)
IE (1) IE75896B1 (no)
IL (1) IL86865A (no)
NO (1) NO882854L (no)
PT (1) PT87997B (no)
RU (1) RU1838419C (no)
ZA (1) ZA885095B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment
ATE122402T1 (de) * 1987-09-04 1995-05-15 Hem Pharma Corp Diagnose von mangelzuständen doppelsträngiger rns.
NO883868L (no) * 1987-09-04 1989-03-06 Hem Res Inc Fremgangsmaate for diagnostisering av dsrna-mangeltilstander, samt fremgangsmaate for fremstilling av preparater for diagnostisering og behandling av slike tilstander.
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
DE68914201T2 (de) * 1988-07-07 1994-07-14 Hem Pharma Corp Diagnose und Behandlung chronischer Ermüdungserscheinungen.
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
AU6740590A (en) * 1989-10-11 1991-05-16 Hem Research, Inc. Protection from shock subsequent to injury by double-stranded rnas
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
CA2113573A1 (en) * 1991-07-16 1993-02-04 William Carter Modulation and diagnosis of cytokine dysfunctions
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
TW524693B (en) * 1997-10-16 2003-03-21 Nippon Shinyaku Co Ltd Cancer cell nuclease activator
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
CN100358534C (zh) * 2005-11-21 2008-01-02 北京百林康源生物技术有限责任公司 错位双链寡核苷酸在制备治疗禽流感病毒感染的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
ZA885095B (en) 1989-07-26
IL86865A (en) 1993-06-10
EP0525917A3 (en) 1993-02-24
PT87997B (pt) 1995-03-01
IE881895L (en) 1989-01-17
PT87997A (pt) 1989-06-30
AU1820388A (en) 1989-01-19
RU1838419C (ru) 1993-08-30
DK363088A (da) 1989-01-18
DE3853898D1 (de) 1995-07-06
FI883351A (fi) 1989-01-18
DK363088D0 (da) 1988-06-30
CA1331345C (en) 1994-08-09
KR970007903B1 (ko) 1997-05-17
KR890002420A (ko) 1989-04-10
FI883351A0 (fi) 1988-07-14
EP0299745A3 (en) 1989-12-06
ATE123222T1 (de) 1995-06-15
ES2075835T3 (es) 1995-10-16
IE75896B1 (en) 1997-09-24
EP0299745A2 (en) 1989-01-18
EP0299745B1 (en) 1995-05-31
JPH01104015A (ja) 1989-04-21
GR3017271T3 (en) 1995-11-30
CN1032741A (zh) 1989-05-10
IL86865A0 (en) 1988-11-30
NO882854L (no) 1989-01-18
EP0525917A2 (en) 1993-02-03
AU1502695A (en) 1995-07-06
DE3853898T2 (de) 1996-02-29
AU1619092A (en) 1992-08-13

Similar Documents

Publication Publication Date Title
NO882854L (no) Korreksjon med dobbeltraadet rna av avvikende metabolske spor forbundet med ukontrollerte vekstsykluser for tumorceller og virus.
Gribble et al. Collagen chain formation and peptidyl proline hydroxylation in monolayer tissue cultures of L-929 fibroblasts
DK165939C (da) Metropololpraeparat med styret, kontinuerlig afgivelse af det aktive stof, farmaceutisk praeparat indeholdende samme og fremgangsmaade til fremstilling af metropololpraeparatet samt anvendelse af metropololpraeparatet til fremstilling af et farmaceutisk praeparat til behandling af kardiovaskulaere lidelser
EP0341904A3 (en) Method for predicting the effectiveness of antineoplastic therapy in individual patients
ATE142691T1 (de) Proteine mit faktor-viii-aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende pharmazeutische zusammensetzungen
ES8307845A1 (es) Procedimiento para preparar una polilactida.
ES8308925A1 (es) Procedimiento de preparacion de material de inoculacion de larga viabilidad y de resistencia a la temperatura mejorada.
EG14187A (en) Improvements in or relating to apparatus for recording,control and early detection of cardiovascular diseases
JPS5379009A (en) Method and composition for increasing essencial bivalent metal level within warm blood animal tissue
EP0289034A3 (en) Transkaryotic implantation
EP0404210A3 (en) A method and probe for the detection of cells associated with human oral medical disorders or with healthy human gingiva
ATE15693T1 (de) Zellkultur-verfahren.
GR3004464T3 (en) Use of paf-antagonists for the preparation of a medicament and method for the determination of their binding-activity
ES8800725A1 (es) Un procedimiento para producir un anticuerpo monoclonal
DE3585049D1 (de) Monoklonale antikoerper.
NO860344L (no) Vevskultur og fremstilling i permeable geler.
ES462975A1 (es) Procedimiento para la preparacion de derivados piperdilide- nicos de xantenos, tioxantenos y dibenzoxepinas.
ZHUKOV et al. An attempt to prevent weather-aggravated cardiovascular diseases
DiGiovanni et al. First Information About N, P Nutrients and the Production of Lake Trasimeno,(In Italian)
JPS5257390A (en) Immobilized enzyme and method of preparing the same
JPS53127888A (en) Preparation of glycerol-dehydrogenase
JPS526593A (en) Method of measuring cholesterol with use of cholesterol esterase
HUT47747A (en) Method for correction defective ways of metabolism related to cycles of growth of spontaneous tomour-cells and viruses, with double-stranded rns
DUDEK Performance, recovery, and man machine effectiveness(Determination of optimal work-rest cycles for individuals and crews to yield high performance and maximum man machine effectiveness)[Semiannual Progress Report, 1 Sep. 1971- 29 Feb. 1972]
JPS5639795A (en) Preparation of interferon